HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Typhoid fever vaccines: systematic review and meta-analysis of randomised controlled trials.

Abstract
We undertook a systematic review and meta-analysis of randomised controlled trials comparing a typhoid fever vaccine with any alternative typhoid fever vaccine or inactive agent. Trials evaluating killed whole-cell vaccines were excluded. The cumulative efficacy at 3 years for the Ty21a and the polysaccharide Vi vaccine were similar: 51% (95%CI 36%, 62%), and 55% (95%CI 30%, 70%), respectively. The cumulative efficacy of the Vi-rEPA vaccine at 3.8 years was higher, 89% (95%CI 76%, 97%), but this vaccine has not yet been licensed for use and was evaluated in only one trial. Adverse events were mild in nature and for most, not significantly more frequent in any of the vaccine groups when compared with placebo. Both the currently licensed Ty21a and Vi vaccine, are safe and efficacious for preventing typhoid fever. Neither vaccine is currently registered for administration to children below 2 years of age. Given the recent finding that typhoid fever also affects infants, development of a conjugate vaccine is warranted.
AuthorsAbigail Fraser, Mical Paul, Elad Goldberg, Camilo J Acosta, Leonard Leibovici
JournalVaccine (Vaccine) Vol. 25 Issue 45 Pg. 7848-57 (Nov 7 2007) ISSN: 0264-410X [Print] Netherlands
PMID17928109 (Publication Type: Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Typhoid-Paratyphoid Vaccines
  • Vaccines, Attenuated
Topics
  • Child
  • Child, Preschool
  • Humans
  • Randomized Controlled Trials as Topic
  • Salmonella typhi (immunology)
  • Typhoid Fever (immunology, prevention & control)
  • Typhoid-Paratyphoid Vaccines (administration & dosage, therapeutic use)
  • Vaccines, Attenuated (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: